Damaged mitochondria in Fanconi anemia - an isolated event or a general phenomenon?

Abstract

Fanconi anemia (FA) is known as an inherited bone marrow failure syndrome associated with cancer predisposition and susceptibility to a number of DNA damaging stimuli, along with a number of clinical features such as upper limb malformations, increased diabetes incidence and typical anomalies in skin pigmentation. The proteins encoded by FA-defective genes (FANC proteins) display well-established roles in DNA damage and repair pathways. Moreover, some independent studies have revealed that mitochondrial dysfunction (MDF) is also involved in FA phenotype. Unconfined to FA, we have shown that other syndromes featuring DNA damage and repair (such as ataxia-telangiectasia, AT, and Werner syndrome, WS) display MDF-related phenotypes, along with oxidative stress (OS) that, altogether, may play major roles in these diseases. Experimental and clinical studies are warranted in the prospect of future therapies to be focused on compounds scavenging reactive oxygen species (ROS) as well as protecting mitochondrial functions.

• Authors: Giovanni Pagano, Pavithra Shyamsunder, Rama S Verma, Alex Lyakhovich
• Journal: Oncoscience (Oncoscience) Vol. 1 Issue 4 Pg. 287-95 ( 2014) ISSN: 2331-4737 [Print] United States
• PMID: 25594021 (Publication Type: Journal Article)